Infectious Disease
FDA Could Approve Pfizer Booster Shots for All Adults This Week
More than 30 million Americans have already gotten booster shots
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
Countries included in licensing deal mostly in Africa and Asia and account for more than half of the world's population
Progress Made in Reducing Depression During Internship
Increases in sleep hours and use of mental health services, decrease in work hours occurred in parallel to decrease in depressive symptoms
Flu Vaccine Coverage Suboptimal for Medicare Beneficiaries
Uptake of vaccination higher among beneficiaries with versus without high-risk conditions; missed opportunities for vaccination are common
9.6 Percent of People of All Ages Uninsured in First Half of 2021
Among adults aged 18 to 64 years, 14.0 percent were uninsured, 21.6 percent had public coverage, 66.3 percent had private health coverage
Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds
BNT162b2 vaccine had favorable safety profile in 5- to 11-year-olds similar to that seen in other age groups
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
Request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness
CDC Warns of E. Coli Outbreak Linked to Baby Spinach
Illness reported in Indiana, Iowa, Michigan, Minnesota, Missouri, Ohio, South Dakota; two hospitalizations but no deaths reported
Salmonella Outbreak Linked to Salami Sticks Rises to 31 Cases in 10 States
There have been six hospitalizations reported, but no deaths
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
However, overall disease activity does not appear to change after vaccination